A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral TherapyAdam M. Spivak, Steven G. Deeks, Adriana Andrade et al.|Clinical Infectious Diseases|2013Cited by 206
Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)Craig W. Hendrix, Kristine B. Patterson, Adriana Andrade et al.|AIDS Research and Human Retroviruses|2015Cited by 177
PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)Roy M. Gulick, Kenneth H. Mayer, Manya Magnus et al.|The Journal of Infectious Diseases|2016Cited by 47
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in WomenRoy M. Gulick, Kenneth H. Mayer, Timothy Wilkin et al.|Annals of Internal Medicine|2017Cited by 31
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)Ian McGowan, Marybeth McCauley, Ian Frank et al.|eScholarship (California Digital Library)|2020Cited by 28